Developer docs
API playgroundTry for free, no card

Search company profiles

National Lipid Association

Full company profile

uuid002cgj1

Namestring
National Lipid Association
Legal namestring
National Lipid Association
Websiteurl
lipid.org
Company typeenum
Private
Founded yearint
1998
Descriptiontext

National Lipid Association (NLA) is a U.S.-based non-profit organization founded in 1998 and headquartered in Jacksonville, Florida, focused on clinical lipid management and cardiovascular disease prevention. According to the available source material, NLA serves healthcare providers — specifically medical professionals specializing in lipidology and cardiovascular health — through four core functions: continuing medical education, development of clinical guidelines, professional certification, and research collaboration in lipid disorders and cardiovascular disease prevention.

The organization's segment strategy is vertical, targeting a narrow subspecialty of practicing clinicians rather than a broad healthcare audience. As a non-profit professional association, NLA's revenue mechanics are not disclosed in the source data, but the functional model is consistent with a membership- and education-based association: dues, CME program fees, conference revenue, certification fees, and potentially journal or publishing revenue. The firmographic indicates a headcount band of 1,001–5,000, which for a subspecialty medical association likely reflects member physicians alongside a smaller employed staff core.

No information on technology platforms, proprietary products, digital offerings, or partnerships was available; the primary website source was blocked by a verification/loader system that prevented access to substantive content about products, leadership, financial details, or strategic activity. The organization appears to operate as a standards-setting and professional development body rather than a technology or product company.

Short descriptiontext

National Lipid Association (NLA) is a U.S. non-profit founded in 1998, headquartered in Jacksonville, Florida, that serves healthcare providers in lipidology and cardiovascular health through continuing medical education, clinical guidelines, professional certification, and research collaboration.

Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersJacksonville, United States
HQ citystring
Jacksonville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
lipid management, clinical guidelines, continuing medical education, cardiovascular prevention, professional certification
Industry2 codes
1Lipidology & Dyslipidemia
CodeHLAKADAKPrimaryYes
2Preventive Cardiology & Lipidology
CodeHLAKABAFPrimaryNo
NAICS code1 code
  • Professional Organizations813920
SIC code1 code
  • Services-Membership Organizations8600
Product category
Medical Professional Association and Clinical Education
Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

National Lipid Association is a nonprofit professional medical association that delivers continuing medical education, clinical practice guidelines, professional certification, and research collaboration opportunities for clinicians focused on lipid disorders and cardiovascular disease prevention. It serves as the recognized specialty society for lipidology in the United States, providing membership services, educational meetings, and certification pathways to its healthcare provider members.

Differentiator
Functional benefit
Problem solved
Product and service5 records
1Professional Membership
CategoryMembership services
2Continuing Medical Education (CME) Programs
CategoryMedical education
3Clinical Practice Guidelines in Lipid Management
CategoryClinical guidelines
4Professional Certification in Lipidology
CategoryProfessional certification
5Scientific Meetings and Annual Conferences
CategoryConferences and meetings
Expansion highlight1 record

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Large US nonprofit covering diabetes, a major comorbidity driving lipid management demand. Comparable professional society and patient-advocacy non-profit model with overlapping clinician audience (endocrinologists, lipidologists, PCPs).

TypeBroad incumbent
Description

Cardiology-focused professional society publishing lipid and CV risk guidelines and offering member education, certification, and advocacy. Overlaps with NLA in lipid and preventive cardiology domains but serves a much larger cardiology membership base.

TypeDirect peer
Description

Specialty clinical endocrinology society that publishes lipid and metabolic guidelines and runs lipid-focused CME. Most directly comparable single-specialty peer in mission, membership model, and clinical scope overlap with NLA.

TypeDirect peer
Description

Nursing-focused preventive cardiology association with overlapping lipid management education and CV risk reduction mission. Comparable small specialty society with CME, certification, and advocacy programs aimed at lipid and CV prevention clinicians.

TypeBroad incumbent
Description

Large, broadly scoped US cardiovascular nonprofit that publishes lipid and preventive cardiology guidance and runs extensive CME and certification. Directly comparable as a professional society serving overlapping clinician audiences (cardiologists, lipidologists, internists), but with significantly broader scope and resources than NLA.

TypeBroad incumbent
Description

Professional society for endocrinologists, a core clinician group that overlaps with lipidology practice (e.g., diabetes-dyslipidemia comorbidity). Comparable in member-driven, CME- and guideline-producing non-profit model.

TypeBroad incumbent
Description

US nonprofit focused on kidney disease with significant overlap in CV–metabolic comorbidity (lipid management in CKD). Comparable as a chronic-disease, member- and donor-supported professional/patient society with CME and guideline activities.

TypeRegional player
Description

Global scientific society for atherosclerosis research and education with closely aligned lipid-management mission. Comparable in scientific and guideline focus but operates internationally rather than US-centric like NLA.

TypeDirect peer
Description

Preventive cardiology specialty society focused on CV risk reduction, including lipid management. Directly comparable niche, mission, and clinician audience to NLA, though smaller and more recently established.

10European Atherosclerosis Society
TypeDirect peer
Description

International scientific society dedicated to atherosclerosis and lipid disorders, publishing major lipid guidelines and running lipidology education. Closely comparable mission and programming to NLA, but operating primarily in Europe.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

National Lipid Association

Medical Professional Association and Clinical Educationlipid.org

National Lipid Association (NLA) is a U.S. non-profit founded in 1998, headquartered in Jacksonville, Florida, that serves healthcare providers in lipidology and cardiovascular health through continuing medical education, clinical guidelines, professional certification, and research collaboration.

What National Lipid Association does

National Lipid Association (NLA) is a U.S.-based non-profit organization founded in 1998 and headquartered in Jacksonville, Florida, focused on clinical lipid management and cardiovascular disease prevention. According to the available source material, NLA serves healthcare providers — specifically medical professionals specializing in lipidology and cardiovascular health — through four core functions: continuing medical education, development of clinical guidelines, professional certification, and research collaboration in lipid disorders and cardiovascular disease prevention.

The organization's segment strategy is vertical, targeting a narrow subspecialty of practicing clinicians rather than a broad healthcare audience. As a non-profit professional association, NLA's revenue mechanics are not disclosed in the source data, but the functional model is consistent with a membership- and education-based association: dues, CME program fees, conference revenue, certification fees, and potentially journal or publishing revenue. The firmographic indicates a headcount band of 1,001–5,000, which for a subspecialty medical association likely reflects member physicians alongside a smaller employed staff core.

No information on technology platforms, proprietary products, digital offerings, or partnerships was available; the primary website source was blocked by a verification/loader system that prevented access to substantive content about products, leadership, financial details, or strategic activity. The organization appears to operate as a standards-setting and professional development body rather than a technology or product company.

National Lipid Association firmographics

Firmographics
Name
National Lipid Association
Legal name
National Lipid Association
Website
https://lipid.org
Company type
Private
Founded year
1998
Headcount range
1,001–5,000 employees
Short description
National Lipid Association (NLA) is a U.S. non-profit founded in 1998, headquartered in Jacksonville, Florida, that serves healthcare providers in lipidology and cardiovascular health through continuing medical education, clinical guidelines, professional certification, and research collaboration.
Ownership category
akta.pro rank

National Lipid Association industry classification

Industry
Product category
Medical Professional Association and Clinical Education
NAICS
Professional Organizations (813920)
SIC
Services-Membership Organizations (8600)
akta.pro primary industry
Lipidology & Dyslipidemia (HLAKADAK)
akta.pro secondary industry
Preventive Cardiology & Lipidology (HLAKABAF)

Keywords

  • Lipid management
  • Clinical guidelines
  • Continuing medical education
  • Cardiovascular prevention
  • Professional certification

Where National Lipid Association is headquartered

Location

Headquarters

HQ city
Jacksonville
HQ country
United States
HQ region
North America

Markets served

National Lipid Association business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

National Lipid Association product offering

Product offering

Core offering

National Lipid Association is a nonprofit professional medical association that delivers continuing medical education, clinical practice guidelines, professional certification, and research collaboration opportunities for clinicians focused on lipid disorders and cardiovascular disease prevention. It serves as the recognized specialty society for lipidology in the United States, providing membership services, educational meetings, and certification pathways to its healthcare provider members.

Differentiator

Problem solved

Functional benefit

Products and services

  • Professional Membership
  • Continuing Medical Education (CME) Programs
  • Clinical Practice Guidelines in Lipid Management
  • Professional Certification in Lipidology
  • Scientific Meetings and Annual Conferences

Companies that use National Lipid Association

Customer profile

Segments1 record

Ideal customer profiles1 record

National Lipid Association technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

National Lipid Association partnerships and signals

Strategic signal

Expansion highlights1 record

National Lipid Association competitors and assessment

Company assessment

Broad incumbents

  • American Diabetes Association: Large US nonprofit covering diabetes, a major comorbidity driving lipid management demand. Comparable professional society and patient-advocacy non-profit model with overlapping clinician audience (endocrinologists, lipidologists, PCPs).
  • American College of Cardiology: Cardiology-focused professional society publishing lipid and CV risk guidelines and offering member education, certification, and advocacy. Overlaps with NLA in lipid and preventive cardiology domains but serves a much larger cardiology membership base.
  • American Heart Association: Large, broadly scoped US cardiovascular nonprofit that publishes lipid and preventive cardiology guidance and runs extensive CME and certification. Directly comparable as a professional society serving overlapping clinician audiences (cardiologists, lipidologists, internists), but with significantly broader scope and resources than NLA.
  • Endocrine Society: Professional society for endocrinologists, a core clinician group that overlaps with lipidology practice (e.g., diabetes-dyslipidemia comorbidity). Comparable in member-driven, CME- and guideline-producing non-profit model.
  • National Kidney Foundation: US nonprofit focused on kidney disease with significant overlap in CV–metabolic comorbidity (lipid management in CKD). Comparable as a chronic-disease, member- and donor-supported professional/patient society with CME and guideline activities.

Direct peers

  • American Association of Clinical Endocrinology: Specialty clinical endocrinology society that publishes lipid and metabolic guidelines and runs lipid-focused CME. Most directly comparable single-specialty peer in mission, membership model, and clinical scope overlap with NLA.
  • Preventive Cardiovascular Nurses Association: Nursing-focused preventive cardiology association with overlapping lipid management education and CV risk reduction mission. Comparable small specialty society with CME, certification, and advocacy programs aimed at lipid and CV prevention clinicians.
  • American Society for Preventive Cardiology: Preventive cardiology specialty society focused on CV risk reduction, including lipid management. Directly comparable niche, mission, and clinician audience to NLA, though smaller and more recently established.
  • European Atherosclerosis Society: International scientific society dedicated to atherosclerosis and lipid disorders, publishing major lipid guidelines and running lipidology education. Closely comparable mission and programming to NLA, but operating primarily in Europe.

Regional players

  • International Atherosclerosis Society: Global scientific society for atherosclerosis research and education with closely aligned lipid-management mission. Comparable in scientific and guideline focus but operates internationally rather than US-centric like NLA.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

National Lipid Association social profiles

Digital presence

National Lipid Association financial estimates

Financial estimate

Revenue estimate

Valuation estimate

National Lipid Association leadership team

Management profile

Number of profiles

National Lipid Association funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

National Lipid Association M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about National Lipid Association

What does National Lipid Association do?

National Lipid Association is a nonprofit professional medical association that delivers continuing medical education, clinical practice guidelines, professional certification, and research collaboration opportunities for clinicians focused on lipid disorders and cardiovascular disease prevention. It serves as the recognized specialty society for lipidology in the United States, providing membership services, educational meetings, and certification pathways to its healthcare provider members.

When was National Lipid Association founded?

National Lipid Association was founded in 1998. It employs 1,001 to 5,000 people.

Where is National Lipid Association based?

National Lipid Association is headquartered in Jacksonville, United States, in the North America region.

Who are National Lipid Association's main competitors?

Broad incumbents on record are American Diabetes Association, American College of Cardiology, American Heart Association, Endocrine Society and National Kidney Foundation. Direct peers are American Association of Clinical Endocrinology, Preventive Cardiovascular Nurses Association, American Society for Preventive Cardiology and European Atherosclerosis Society. International Atherosclerosis Society is listed as a regional player.

Does National Lipid Association have an API?

No public API is recorded for National Lipid Association.

What industry is National Lipid Association in?

National Lipid Association's product category is Medical Professional Association and Clinical Education. Its primary akta.pro industry code is HLAKADAK, Lipidology & Dyslipidemia, with a secondary code of HLAKABAF, Preventive Cardiology & Lipidology. Its NAICS code is 813920 and its SIC code is 8600.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BioSpaceNewAmsterdam Pharma Announces Upcoming Presentations at the National Lipid Association (NLA) 2026 Scientific SessionsNewAmsterdam Pharma will present data on obicetrapib at the NLA 2026 Scientific Sessions in Chicago, June 11-14. The company will report on safety, kidney function, and cardiovascular outcomes from its Phase 3 trials, including the randomized PREVAIL trial with over 9,500 patients.GlobeNewswireCardiometabolic Health Congress to Present at the National Lipid Association 2023 Scientific SessionsCMHC will present an abstract at the National Lipid Association 2023 Scientific Sessions on educational outcomes from a CME activity improving clinician knowledge about LDL-C lowering after myocardial infarction. The poster details findings from the CME program, including real-world evidence on suboptimal LDL-C goals and intensification of therapy.GlobeNewswireEsperion Announces Five Abstracts Accepted for Presentation at the National Lipid Association Scientific SessionsEsperion announced five abstracts accepted for presentation at the National Lipid Association Scientific Sessions in Scottsdale, Arizona. The abstracts cover bempedoic acid efficacy and safety in patients with renal impairment, metabolic syndrome, hypertension, and a nationwide analysis of lipid-lowering therapy. The company also highlighted real-world data on therapy usage gaps.GlobeNewswireNational Lipid Association and Paradigm Medical Communications, LLC Announce Collaborative Partnership in Lipids EducationThe National Lipid Association and Paradigm Medical Communications announced a partnership to develop an 18-month blended learning curriculum on LDL-C management, launching May 2021. The initiative is funded by an educational grant from Novartis.GlobeNewswireAmarin Highlights Multiple VASCEPA® (Icosapent Ethyl)-Related Scientific Findings Presented at National Lipid Association (NLA) Scientific Sessions 2020, Including First COVID-19 Clinical ResultsAmarin presented VASCEPA findings at NLA 2020, including REDUCE-IT data showing EPA levels correlated with cardiovascular outcomes and a COVID-19 trial reporting a 25% hsCRP reduction. The company also highlighted mechanism-of-action studies and a webcast discussion.GlobeNewswireNational Lipid Association Releases Official Scientific Statement on Coronary Artery Calcium Scoring for ASCVD Risk ReductionThe National Lipid Association released a scientific statement on coronary artery calcium scoring for ASCVD risk reduction, providing evidence-based recommendations for clinicians. The statement covers optimal timing for repeat testing, use in statin-treated patients, and guidance on aspirin and anti-hypertensive therapy. It is in press with the Journal of Clinical Lipidology.GlobeNewswireNational Lipid Association Announces Late-Breaking Abstract Presentations at NLA 2020 Virtual Scientific SessionsThe National Lipid Association announced three late-breaking abstract presentations at its 2020 Virtual Scientific Sessions on Saturday, December 12, 2020. The presentations cover a first human trial of a loading dose of icosapent ethyl in COVID-19 patients, reductions in lipoprotein(a) with inclisiran, and EPA levels and cardiovascular outcomes in the Encore trial.GlobeNewswireVASCEPA® (Icosapent Ethyl)-Related Scientific Findings to Be Presented at National Lipid Association (NLA) Scientific Sessions 2020Amarin announced that VASCEPA-related scientific findings will be presented at the National Lipid Association Scientific Sessions 2020, including two Late Breaker and six e-Poster presentations. The presentations cover REDUCE-IT results, a COVID-19 trial, and mechanism-of-action insights. The sessions are held virtually from December 10-12, 2020.GlobeNewswireNational Lipid Association Releases Official Scientific Statement on Genetic Testing in DyslipidemiaThe National Lipid Association released a scientific statement on genetic testing in dyslipidemia, offering guidance on benefits, risks, and patient preferences. The statement emphasizes genetic counseling and outlines limitations, with recommendations for clinicians. It is in press with the Journal of Clinical Lipidology.GlobeNewswireNational Lipid Association (NLA) and the Foundation of the NLA Honors Renowned Cardiologist Dr. Vera Bittner with Distinguished Achievement AwardThe National Lipid Association and its Foundation selected Dr. Vera Bittner as the 2019 recipient of the W. Virgil Brown Distinguished Achievement Award & Lectureship, announced at the NLA 2019 Scientific Sessions on May 18. The award honors exemplary clinicians in lipidology, and Dr. Bittner is a professor at UAB and past NLA president.